| Bronvermelding: | -Hiemke et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2017
-Weigmann H , Härtter S , Maehrlein S et al. Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography J Chromatogr B Biomed Sci Appl 2001 ; 759 : 63 – 71
-Skogh E , Reis M , Dahl M L et al. Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting . Ther Drug Monit 2002 ; 24 : 518 – 526
-Perry P J , Sanger T , Beasley C . Olanzapine plasma concentrations and clinical response in acutely III schizophrenic patients . J Clin Psychopharmacol 1997 ; 17 : 472 – 477
-Nozawa M , Ohnuma T , Matsubara Y et al. The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics . Ther Drug Monit 2008 ; 30 : 35 – 40
-Mamo D , Kapur S , Keshavan M et al. D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia . Neuropsychopharmacology 2008 ; 33 : 298 – 304
-Gex-Fabry M , Balant-Gorgia A E , Balant L P . Therapeutic drug monitoring of olanzapine: the combined eff ect of age, gender, smoking, and comedication . Ther Drug Monit 2003 ; 25 : 46 – 53
-Feng Y , Pollock B G , Coley K et al. Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study . J Clin Pharmacol 2008 ; 66 : 629 – 639
-Citrome L , Stauff er V L , Chen L et al. Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia . J Clin Psychopharmacol 2009 ; 29 : 278 – 283
-Bergemann N , Frick A , Parzer P et al. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients . Pharmacopsychiatry 2004 ; 37 : 63 – 68
-Bech P , Gex-Fabry M , Aubry J M et al. Olanzapine plasma level in relation to antimanic eff ect in the acute therapy of manic states . Nord J Psychiatry 2006 ; 60 : 181 – 182
-Bachmann C J , Haberhausen M , Heinzel-Gutenbrunner M et al. Large intraindividual variability of olanzapine serum concentrations in adolescent patients . Ther Drug Monit 2008 ; 30 : 108 – 112
|
